Generic Product News (January 2021)

Publication
Article
Pharmacy TimesJanuary 2021
Volume 89
Issue 1

Four generic drugs are featured in the January issue of Pharmacy Times®.

Manufactured by Glenmark Pharmaceuticals Inc

Compare to: Prograf

The FDA has approved the immunosuppressive tacrolimus capsules USP in 0.5-, 1-, and 5-mg dosages, indicated for use with other medications for the prevention of organ rejection in patients who have had a heart, kidney, or liver transplant. The capsules can cause serious adverse effects, including an increased risk of some types of cancer and infection, according to a company statement. Other potential adverse effects include anemia, diabetes, heart problems, high blood pressure, high levels of potassium in the blood, kidney problems, and nervous system problems.

FOR MORE INFORMATION: glenmarkpharma.com

Manufactured by Dr. Reddy’s

Compare to: Quelicin

Available in multidose vials, the new succinylcholine chloride injection by Dr. Reddy’s is a paralytic indicated as an adjunct to general anesthesia to facilitate tracheal intubation and relax the muscles during surgery or other medical procedures. It is contraindicated in people with familial or personal history of known hypersensitivity to the drug, malignant hyperthermia, and skeletal muscle myopathies. Adverse effects can include arrhythmias, cardiac arrest, high or low blood pressure, malignant hyperthermia, and rapid or slow heart rate. The Quelicin brand had a market value of about $74.8 million for the 12 months ended September 2020, according to IQVIA data.

FOR MORE INFORMATION: drreddys.com

Manufactured by Camber Pharmaceuticals Inc

Compare to: Sporanox

Camber is now offering itraconazole oral solution, an antifungal medication used in adults to treat infections that are caused by certain fungi, including those in the fingernails, lungs, mouth, throat, or toenails. It should not be taken by anyone with a history of heart failure or kidney or liver disease, and its efficacy and safety have not been established in children. Common adverse effects may include dizziness, fever, headache, increased blood pressure, nausea, rash, and swelling.

FOR MORE INFORMATION: camberpharma.com

Manufactured by Amneal Pharmaceuticals Inc

Compare to: Zovirax

Indicated for the treatment of recurrent herpes labialis in immunocompetent individuals who are 12 years or older, Amneal’s acyclovir cream is available in a 5% dosage strength. It can cause serious adverse effects, including easy bleeding or bruising, purple or red pinpoint spots under the skin, shortness of breath, and swelling in the ankles or feet. Zovirax had a market value of about $67 million for the 12 months ended September 2020, according to IQVIA data.

FOR MORE INFORMATION: amneal.com

Related Videos
Practice Pearl #1 Active Surveillance vs Treatment in Patients with NETs
© 2024 MJH Life Sciences

All rights reserved.